Health Sciences Group, Inc. (HESG)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 12, 2025
Health Sciences Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | 2000 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '06 Sep 30, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 | Dec '02 Dec 31, 2002 | Dec '01 Dec 31, 2001 | 2000 |
| Revenue | 0.07 | 0.06 | 0.07 | 5.37 | 5.54 | 0.34 | Upgrade
|
| Revenue Growth (YoY) | 235.79% | -10.51% | -98.75% | -3.12% | 1520.18% | - | Upgrade
|
| Cost of Revenue | 0.06 | 0.04 | 0.02 | 3.82 | 4.05 | 0.26 | Upgrade
|
| Gross Profit | 0.01 | 0.02 | 0.05 | 1.54 | 1.49 | 0.08 | Upgrade
|
| Selling, General & Admin | 4.85 | 6.38 | 3.78 | 4.21 | 4.81 | 0.89 | Upgrade
|
| Research & Development | 0.06 | 0.06 | 0.01 | 0.05 | 0.05 | 0.02 | Upgrade
|
| Operating Expenses | 5.14 | 6.72 | 3.98 | 4.8 | 5.57 | 0.91 | Upgrade
|
| Operating Income | -5.12 | -6.69 | -3.94 | -3.26 | -4.08 | -0.83 | Upgrade
|
| Interest Expense | -0.63 | -1.07 | -0.69 | -0.88 | -0.2 | -0 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | - | 0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.75 | 3.42 | 0.79 | -0.67 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -3 | -4.35 | -3.84 | -4.81 | -4.28 | -0.74 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -0.55 | - | - | Upgrade
|
| Asset Writedown | -0.64 | -0.44 | -0.99 | - | - | - | Upgrade
|
| Other Unusual Items | -0.11 | -0.79 | -0.61 | - | - | - | Upgrade
|
| Pretax Income | -3.75 | -5.58 | -5.44 | -5.36 | -4.28 | -0.74 | Upgrade
|
| Earnings From Continuing Operations | -3.75 | -5.58 | -5.44 | -5.36 | -4.28 | -0.74 | Upgrade
|
| Earnings From Discontinued Operations | -0.01 | -0.17 | -5.01 | -2.06 | - | - | Upgrade
|
| Net Income | -3.76 | -5.75 | -10.45 | -7.42 | -4.28 | -0.74 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.39 | 0.34 | 0.51 | 1.03 | - | - | Upgrade
|
| Net Income to Common | -4.15 | -6.09 | -10.96 | -8.45 | -4.28 | -0.74 | Upgrade
|
| Shares Outstanding (Basic) | 33 | 25 | 14 | 11 | 6 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 25 | 14 | 11 | 6 | 3 | Upgrade
|
| Shares Change (YoY) | 56.13% | 73.87% | 27.24% | 90.24% | 77.24% | 134.96% | Upgrade
|
| EPS (Basic) | -0.13 | -0.25 | -0.78 | -0.76 | -0.73 | -0.22 | Upgrade
|
| EPS (Diluted) | -0.13 | -0.25 | -0.78 | -0.76 | -0.73 | -0.22 | Upgrade
|
| Free Cash Flow | -0.18 | -3.74 | -1.06 | -2.59 | -0.62 | -0.37 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.15 | -0.07 | -0.23 | -0.10 | -0.11 | Upgrade
|
| Gross Margin | 19.31% | 38.10% | 69.44% | 28.79% | 26.88% | 24.28% | Upgrade
|
| Operating Margin | -7390.57% | -11129.55% | -5856.43% | -60.71% | -73.67% | -241.50% | Upgrade
|
| Profit Margin | -5987.44% | -10132.54% | -16307.23% | -157.45% | -77.35% | -215.06% | Upgrade
|
| Free Cash Flow Margin | -265.64% | -6217.15% | -1572.64% | -48.34% | -11.11% | -108.31% | Upgrade
|
| EBITDA | -4.51 | -6.01 | -3.79 | -2.96 | -3.79 | -0.79 | Upgrade
|
| EBITDA Margin | - | - | - | -55.20% | -68.51% | -231.87% | Upgrade
|
| D&A For EBITDA | 0.61 | 0.68 | 0.15 | 0.3 | 0.29 | 0.03 | Upgrade
|
| EBIT | -5.12 | -6.69 | -3.94 | -3.26 | -4.08 | -0.83 | Upgrade
|
| EBIT Margin | - | - | - | -60.71% | -73.67% | -241.50% | Upgrade
|
| Advertising Expenses | - | - | - | - | 0 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.